BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:22 PM
 | 
Jul 05, 2007
 |  BC Extra  |  Clinical News

Cosmo's rifamycin SV MMX meets primary endpoint

Cosmo (SWX:COPN) said preliminary data from a Phase II/III trial to treat travelers' diarrhea showed that rifamycin SV MMX (

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >